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1. Introduction 
The fluidity of lipid domains can markedly affect 
the lateral and rotational diffusion [l] , as well as the 
degree of exposure [2-4], of membrane proteins. It 
is therefore believed that some of the control mecha- 
nisms of membrane functions involve the lipid 
fluidity. Under physiological conditions modulation 
of the fluidity of the membrane lipid domains is 
achieved by changes in the mole ratio of cholesterol 
to phospholipid (C/PL) [5,6] , changes in the mole 
ratio of lecithin to sphingomyelin (L/S) [6,7] , or 
changes in the overall degree of unsaturation of the 
phospholipid acyl chains. 
One of the main mechanisms of changing the C/PL 
in cell membranes is the passive partitioning of 
cholesterol between the serum lipoproteins and the 
cell plasma membrane. Under normal physiological 
conditions the C/PL levels in the serum and the cell 
membrane are at an equilibrium which is enforced by 
a steady-state of cholesterol exchange between these 
reservoirs [8] . However, alterations of the C/PL of 
the ambient serum will lead to translocation of cho- 
lesterol towards a new equilibrium state which will 
eventually alter the C/PL of the cell membrane. This 
mechanism is considered to be the main passive 
physiological process which modulates membrane 
fluidity in animal tissues. 
Essentially, all the available in vitro techniques for 
modulation of cellular cholesterol involve treatments 
with liposomes of abnormally high C/PL for cholesterol 
enrichment or liposomes free of cholesterol for 
cholesterol depletion. In most of these procedures the 
treated cells are incubated in the liposomes in the 
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presence of serum for 12-36 h. The methods using 
liposomes have been extensively used in studies of 
blood cells, mostly erythrocytes [5,9] , platelets [lo] 
and lymphocytes [ 1 l] . Unfortunately, the use of 
liposomes in tissue culture of most growing cells bears 
some undesired effects caused by non-specific adsorp- 
tion and fusion of the liposomes with the cell mem- 
brane [12,13] which in the extreme cases may lead 
to the cell death. 
In the following we present a simple and efficient 
method for cholesterol enrichment or depletion of 
cell membranes which is especially pertinent to cells 
in tissue culture. The effectiveness of the method 
is demonstrated in human red blood cells and in mouse 
spleen cells. 
2. Materials and methods 
Cholesterol (CH-S) and egg-lecithin in chloroform- 
methanol were obtained from Sigma. The lecithin 
solution was brought to complete dryness under 
argon before use. Tetrahydrofuran was purchased 
from Fisher Chemicals. Sera and media for tissue 
culture were obtained from local sources. 
Freshly drawn human blood was obtained from a 
normal donor. The red blood cells were separated by 
centrifugation and washed 3 times with phosphate 
buffered saline (PBS). The removed plasma was incu- 
bated at 56°C for 30 min and the heat-inactivated 
serum was separated by centrifugation and was used 
in the treating media. Mouse spleen cells were obtained 
from a 10 weeks old BALB/c mouse. 
The methods for cholesterol enrichment or deple- 
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tion, which are described in the following, are based 
on introduction of finely dispersed cholesterol or 
egg lecithin into serum-medium mixtures. The out- 
lined procedures gave optimal results with the various 
tested cells, though variations in quantities and condi- 
tions may be applied for each specific case. 
2.1. Serum -medium mixtures 
Mixtures of 10% heat-inactivated serum in medium 
supplemented with antibiotics, which are routinely 
used in tissue culture, are used in the methods for 
modulating the contents of membrane cholesterol. 
For most cells a mixture of heat inactivated fetal calf 
serum in Eagle’s medium is appropriate. In treatments 
of low metabolic activity systems (erythrocytes, 
platelets, fixed cells and isolated membranes) a mix- 
ture of heat inactivated human serum in PBS contain- 
ing 2 mg/ml glucose is adequate. 
2.2. Lipid solvent 
A mixture of 5: 1 (v/v) tetrahydrofuran and 0.6% 
aqueous KC1 (‘THF’) is used as a dispersing solvent for 
cholesterol or egg lecithin [ 141 . 
2.3. Cholesterol-enriching medium 
One volume of solution of l-l 5 mg/ml cholesterol 
in THF is introduced into 10 vol. vigorously stirred 
serum-medium mixture in a lyophilization vessel 
(practically 10 ml THF solution into 100 ml serum- 
medium). When applying to mixtures containing 
human serum the cholesterol in THF can be increased 
to 2 mg/ml. The mixture is freezed and then lyo- 
philized to complete dryness. The dried material is 
weighed and standardized for reconstitution. The 
cholesterol-enriching medium is prepared before each 
treatment by dissolving the lyophilized material in 
the proper volume of sterile distilled water. 
2.4. Cholesterol-depleting medium 
A solution of 2-3 mg/ml egg lecithin in THF is 
mixed with the serum-medium and processed identi- 
cally to the previous procedure. When human serum 
is used the lecithin in THF can be increased to 5 mg/ml. 
2.5 . Control medium 
One volume of free THF is mixed with 10 vol. 
serum-medium and the mixture is processed as the 
above two media. 
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2.6. l7re DMSO modification 
Dimethyl sulfoxide (DMSO) is well tolerated by 
cells at concentrations below 2%. Cholesterol, 
lo-15 mg, is dissolved in 1 ml hot DMSO (% 80°C. 
The solution is diluted 1: 100 (v/v) while hot by squirt- 
ing into the vigorously stirred serum-medium. The 
obtained mixture is used as such for cholesterol 
enrichment. For cholesterol depletion 20-30 mg egg 
lecithin are dissolved in hot DMSO and diluted 1: 100 
(v/v) analogously with serum-medium. The control 
mixture is of l%DMSO in the serum-medium mixture. 
2.7. Cholesterol modulation assays 
Red blood cells are incubated in the reconstituted 
medium at a concentration of 1 ml packed cells/ 
lo-25 ml medium. The incubation is carried out at 
37’C with shaking in loosely covered vials for up to 
36 h. The treated cells are washed 3 times with PBS 
and are processed for membrane preparation [ 151 
and lipid analysis. In this report free cholesterol was 
analysed by the FeCls method [ 161 and the phospho- 
lipids were determined by organic phosphorus analysis 
1171. 
Treatments of cells in tissue culture are carried out 
analogously to growth conditions (106-10’ cells/ml). 
The C/PL can be estimated indirectly by measuring 
the microviscosity of the cell membrane [6] or by 
monitoring a certain membrane function. 
3. Results and discussion 
Cholesterol acquisition by cell membranes occurs 
when the serum is abnormally rich in unesterified 
cholesterol. Such a conditions prevails in cirrhosis 
where the level of free cholesterol is 2-3-fold greater 
than normal while all other lipid components remain 
in the normal range [ 181. The cirrhotic serum indi- 
cates that the capacity of normal sera for free choles- 
terol may be several-fold greater than the amount 
present. Since the concentration of free cholesterol in 
most normal sera is around 0.3-I mg/ml it may be 
expected that a normal serum could accomodate 
additional cholesterol of up to about 2 mg/ml. This 
assumption furnished the basis for the described 
method. 
The incorporation of the added cholesterol into 
the serum lipoproteins could be assessed by the trans- 
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parency of the reconstituted enriched serum-medium 
(see section 2). After reconstitution the cholesterol 
enriching or depleting media exhibit only sljght trans- 
lucence as compared with the control medium. The 
turbidity was estimated by measuring A6s0 nm against 
the control medium. The use of THF-aqueous KC1 
[ 141 as a dispersing solvent under the conditions 
described in sections 2.3 and 2.4 gave optimal results 
according to the turbidity criteria. In addition, no 
precipitation could be detected after centrifugation 
of the reconstituted media at 30 000 X g for 1 h. It is 
therefore reasonable to assume that before lyophiliza- 
tion the dispersed cholesterol or lecithin were mostly 
in monomeric or oligomeric forms which during the 
slow process of freeze-drying integrated into the 
serum lipoproteins. However, no other evidence as for 
the location and distribution of the added cholesterol 
or lecithin is yet available. 
Most studies on modulation of membrane choles- 
terol were carried out with human erythrocytes 
[3-5,9] . Figure 1 presents the results of a series of 
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Fig. 1. The change in cholesterol to phospholipid mole ratio 
of human erythrocytes upon incubation with the cholesterol- 
enriching (a), the cholesterol-depleting (A) and the control 
media (0). The fiied marks present experimental data 
obtained independently by Dr S. Ip from the University 
of Pennsylvania. 
treatments of human erythrocytes by the described 
method. Both the phospholipid and the protein 
contents per cell remained virtually unaltered through- 
out the treatments, and the observed changes in 
C/PL were exclusively due to changes in the absolute 
amount of cholesterol per cell. Similar results were 
obtained [5,9] for treatments of erythrocytes with 
liposomes. However, the total lipid concentration 
required for the treatments with liposomes is over 
lo-fold greater than in the present method. 
Superficial screening of a series of normal and 
transformed cell lines has indicated that the described 
media did not cause any significant alterations in 
cell viability in treatments which lasted less than 24 h. 
Because of technical difficulties, we have not isolated 
the membranes of the treated cells for determination 
of C/PL, and the efficiency of the method was 
inferred indirectly by parameters like morphology, 
agglutination and membrane microviscosity [6,1 l] . 
In lymphocytes determination of microviscosity (ii) 
by fluorescence polarization of 1,6-diphenyl 1,3,5- 
hexatriene (DPH) is believed to relate almost 
exclusively to the plasma membrane [6,1 l] . Figure 2 
describes the change in the degree of fluorescence 
polarization (P) of mouse spleen cells labelled with _ 
0.340 , , , , 1 , I , , , I , 
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0.220’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ I ’ ’ 
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Fig.2. The change in the degree of fluorescence polarization 
(P) of mouse spleen cells labelled with DPH after incubation 
with the cholesterol enriching (o), the cholesterol depleting 
(A) and the control media (0). The figure also presents the 
estimated fi and C/PL values after 12 h incubation. 
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DPH after treatments with the cholesterol modulating 
media. The figure also presents the estimated values 
of 5 and C/PL after 12 h treatment. 
The described method offers important advantages 
over the commonly used methods for cholesterol 
modulation. It is carried out under conditions which 
are close to physiological, and it is highly efficient 
and reproducible. In principle, this method could be 
also applied for enrichment with other lipophilic 
materials ike steroids, fatty acids, carcinogens and 
drugs. 
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